1. MicroRNA-21 Expression in Primary Breast Cancer Tissue Among Egyptian Female Patients and its Correlation with Chromosome 17 Aneusomy
   Noura Ramadan Abdel-hamid et al, 2015, Molecular Diagnosis & Therapy CrossRef
2. Results of mutation status gene HER-2/NEU in patients with breast cancer in Ukraine
   B. T. Klimuk et al, 1970, Faktori eksperimental'noi evolucii organizmiv CrossRef
3. Comparison of the 2007 and 2013 ASCO/CAP evaluation systems for HER2 amplification in breast cancer
   Xiaohong Pu et al, 2015, Pathology - Research and Practice CrossRef
4. The Clinicopathologic and Prognostic Value of Altered Chromosome 17 Centromere Copy Number in HER2 Fish Equivocal Breast Carcinomas
   Hongfei Ji et al, 2015, PLOS ONE CrossRef
5. Amplification of Chromosome 17 Centromere (CEP17) in Breast Cancer Patients with a Result of HER2 2± by Immunohistochemistry
   Vanessa Davies et al, 2020, Cancer Investigation CrossRef
6. EGFR amplification and expression in oral squamous cell carcinoma in young adults
   V. Costa et al, 2018, International Journal of Oral and Maxillofacial Surgery CrossRef
7. High prevalence of chromosome 17 in breast cancer micronuclei: a means to get rid of tumor suppressors?
   Laxmi Kumari et al, 2024, Human Cell CrossRef
8. EGFR is not amplified in ameloblastoma
   Victor Costa et al, 2018, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
9. The FlexISH assay brings flexibility to cytogenetic HER2 testing
   Gero Brockhoff et al, 2016, Histopathology CrossRef